方法：对41例47眼合并角膜散光的白内障患者行超声乳化白内障吸出及IOL植入术治疗，进行回顾性分析。其中22眼植入Toric IOL，25眼植入Acrysof IQ IOL。术后随访6mo，分析不同时间点裸眼视力、术后残余散光、并发症等，比较两种IOL的疗效。观察Toric IOL植入后的稳定性。

结果： 术后随访观察6mo，植入Toric IOL的试验组，术后裸眼视力平均0.73±0.37，明显优于植入Acrysof IQ IOL的对照组(平均0.47±0.18)，结果有显著性差异。试验组术后裸眼视力0.5以上者占81.8%，优于对照组32.0%。试验组患者术后残余散光0.53±0.40D，明显低于对照组(2.13±0.76D)，差异有统计学意义。植入Toric IOL组，随访6mo，术后平均旋转4.22±1.46度。

结论：对于合并角膜散光的白内障患者，行白内障超声乳化吸出联合Toric IOL植入，能够安全、有效的改善患者的散光，提高术后视觉质量，预测性好。

METHODS: Forty-seven eyes in 41 patients with cataract and corneal astigmatism had toric IOL(22 eyes)or spherical IOL(25 eyes)implantation during phacoemulsification. Outcome measures were uncorrected distance visual acuity(UDVA), best-corrected distance visual acuity(BCDVA), postoperative refractive cylinder, toric IOL axis rotational stability and complications.

RESULTS: Six months postoperatively, the mean UDVA was(0.73±0.37)in toric IOL group and(0.47±0.18)in spherical IOL group; the UDVA was better than 0.50 of 81.8% and 32.0% in two groups, respectively. The residual astigmatism was(0.53±0.40)D in toric IOL group and(2.13±0.76)D in spherical IOL group. The mean toric IOL misalignment was(4.22±1.46)degrees.

CONCLUSION: Implantation of toric IOL during cataract surgery is effective, predictable and safe in correcting corneal astigmatism.